Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting neurological disorders. Shows potential in the development of nicotinic acetylcholine receptor modulators, which are relevant for treating cognitive impairments and neurodegenerative diseases like Alzheimer's. Also employed in medicinal chemistry for constructing pyridylisoxazole-based scaffolds that exhibit anti-inflammatory and anticonvulsant activities. Its derivatization supports structure-activity relationship studies aimed at optimizing drug candidates.